Tae Yoon Lee

Dr. Tae Yoon Lee


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2013 in Analytical Chemistry
Verified
Journal Article
Closed access
KHKyung-A Hyun
Kyung-A Hyun
TLTae Yoon Lee
Tae Yoon Lee
HJHyo-Il Jung
Hyo-Il Jung

1 May 2015 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
KHKyung-A Hyun
Kyung-A Hyun
TLTae Yoon Lee
Tae Yoon Lee
SLSu Hyun Lee
Su Hyun Lee
Hyo-Il JungHyo-Il Jung
Hyo-Il Jung

1 January 2017 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
TLTae Yoon Lee
Tae Yoon Lee
KHKyung-A Hyun
Kyung-A Hyun
SKSeung-Il Kim
Seung-Il Kim
HJHyo-Il Jung
Hyo-Il Jung

30 July 2018 in Advanced Science
Verified
Journal Article
Open access
PDF file
CJChoong Eun Jin
Choong Eun Jin
BKBonhan Koo
Bonhan Koo
TLTae Yoon Lee
Tae Yoon Lee
KHKyudong Han
Kyudong Han
SLSeok Byung Lim
Seok Byung Lim
YSYong Shin
Yong Shin
Cell‐free nucleic acids (cfNAs) are emerging diagnostic biomarkers for monitoring the treatment and recurrence of cancers. In particular, the biological role and clinical usefulness of cfNAs obtained from the plasma of patients with various cancers are popular and still intensely explored, yet most studies are limited by technical problems during cfNA isolation. A dimethyl dithiobispropionimidate (DTBP)‐based microchannel platform that enables spontaneous cfNA capture in 15 min with minimal cellular background and no requirements for use of bulky instruments is reported first. This platform identified KRAS and BRAF hot‐spot mutations following cfDNA isolation from the blood plasma and tissues obtained from 30 colorectal cancer patients. The correlation of mutations between the primary tissues and plasma from the patients was high using this platform with whole genome sequencing compared to the spin‐column method. This platform can also be combined with various detection approaches (biooptical sensor, Sanger sequencing, and polymerase chain reaction (PCR)) for rapid, simple, low‐cost, and sensitive circulating tumor DNA detection in blood plasma. The efficiency and versatility of this platform in isolating cfNAs from liquid biopsies has applications in cancer treatment and precision medicine.

12 January 2023 in Analytica Chimica Acta
Verified
Journal Article
Closed access
KNKarikalan Natarajan
Karikalan Natarajan
AYAnnamalai Yamuna
Annamalai Yamuna
TLTae Yoon Lee
Tae Yoon Lee

1 April 2017 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
BKBonhan Koo
Bonhan Koo
CJChoong Eun Jin
Choong Eun Jin
TLTae Yoon Lee
Tae Yoon Lee
JLJeong Hoon Lee
Jeong Hoon Lee
MPMi Kyoung Park
Mi Kyoung Park
YSYong Shin
Yong Shin